机译:下一代测序揭示了DRB3〜* 02:02与1型糖尿病的关联
Roche Molecular Systems, Pleasanton, California;
King's College London, London, U.K.;
Children's Hospital Oakland Research Institute, Oakland, California;
454 Life Sciences-a Roche Company, Branford, Connecticut;
454 Life Sciences-a Roche Company, Branford, Connecticut;
454 Life Sciences-a Roche Company, Branford, Connecticut;
Department of Medical Genetics, Cambridge Institute of Medical Research, JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge, U.K.;
Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia;
Children's Hospital Oakland Research Institute, Oakland, California;
机译:通过基于排序的键入,新型HLA-DRB3 * 02:142 HLA-DRB3 * 02:142 HLA-DRB3 * 02:142等位基因的表征
机译:新型HLA-DRB3 * 02:02:23HLA-DRB3 * 02:02:23通过排序的键入表征
机译:通过排序的键入表征新的HLA-DRB3 * 02:02:17 HLA-DRB3 * 02:02:17等位基因
机译:暴露测量误差对解释暴露于PM,N02或S02的流行病学结果的影响:误差类型对偏差和覆盖率的影响
机译:识别推定的p型ATP酶泵,其在牙科蛋白麦芽菌菌菌株02(麦芽酚02)中可以在斯内诺科托洛菌菌菌株02中赋予金和铜抗性
机译:下一代测序揭示了DRB3 * 02:02与1型糖尿病的关联
机译:序列特异性寡核苷酸探针对HLA-A,B,C,DRB1,DRB3 / B4 / B5,DQA1,DQB1,DPA1和DPB1打字的下一代测序:朝着支持的单通高分辨率HLA固体器官和造血细胞移植程序